High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1 –infected patients with severe chronic kidney disease
Liver International, EarlyView.
Source: Liver International - Category: Gastroenterology Source Type: research
More News: Chronic Kidney Disease | Gastroenterology | Hepatitis | Hepatitis C | Liver | Norvir | Urology & Nephrology